Literature DB >> 22740504

Validation and comparison of currently available stratification systems for patients with diabetes by risk of foot ulcer development.

M Monteiro-Soares1, A Vaz-Carneiro, S Sampaio, M Dinis-Ribeiro.   

Abstract

AIMS/HYPOTHESIS: There are five systems to stratify the risk for the development of a diabetic foot ulcer (DFU). This study aimed to prospectively validate all of them in the same cohort of participants to allow their direct comparison.
METHODS: A retrospective cohort study was conducted on all patients with diabetes but without an active DFU attending our podiatry section (n=364) from January 2008 to December 2010. Participants' characteristics and all variables composing the stratification systems were assessed at baseline. Follow-up was performed for 1 year or until DFU occurred.
RESULTS: Participants had a mean age of 64 years; 99.7% had type 2 diabetes and 48.6% were male. Median follow-up was 12 months (1-12) during which 33 subjects (9.1%) developed a DFU. Age, diabetes duration, foot deformity, peripheral vascular disease, diabetic peripheral neuropathy, previous DFU, and previous lower extremity amputation were associated with DFU occurrence. All systems presented greater DFU occurrence frequency as the risk group was higher (χ(2), P<0.001) and showed good diagnostic accuracy values, especially negative predictive value (≥ 95%) and area under the receiver operating curve (≥ 0.73). The lowest performance concerned positive predictive value (≤ 29.5%). CONCLUSIONS/
INTERPRETATION: All the currently available stratification systems show high accuracy to detect which patients will develop a DFU with no significant differences among them. Therefore, for diabetic foot screening and resource allocation, it would be desirable to have a single unified system, combining the available systems, prospectively validated in a multicenter context and testing the inclusion of novel predictive variables' pertinence.

Entities:  

Mesh:

Year:  2012        PMID: 22740504     DOI: 10.1530/EJE-12-0279

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  7 in total

Review 1.  Serum Uric Acid Levels and Diabetic Peripheral Neuropathy in Type 2 Diabetes: a Systematic Review and Meta-analysis.

Authors:  Shuai Yu; Ying Chen; Xu Hou; Donghua Xu; Kui Che; Changgui Li; Shengli Yan; Yangang Wang; Bin Wang
Journal:  Mol Neurobiol       Date:  2015-01-12       Impact factor: 5.590

2.  Clinical decision support software for diabetic foot risk stratification: development and formative evaluation.

Authors:  Deborah E Schoen; David G Glance; Sandra C Thompson
Journal:  J Foot Ankle Res       Date:  2015-12-12       Impact factor: 2.303

3.  Reliability and validity of the perfusion, extent, depth, infection and sensation (PEDIS) classification system and score in patients with diabetic foot ulcer.

Authors:  Fengning Chuan; Kang Tang; Peng Jiang; Bo Zhou; Xiaoqun He
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

Review 4.  Clinician Assessment Tools for Patients with Diabetic Foot Disease: A Systematic Review.

Authors:  Raúl Fernández-Torres; María Ruiz-Muñoz; Alberto J Pérez-Panero; Jerónimo C García-Romero; Manuel Gónzalez-Sánchez
Journal:  J Clin Med       Date:  2020-05-15       Impact factor: 4.241

5.  Prevalence of Foot At-Risk and its Associated Characteristics among Outpatients with Diabetes Mellitus in a Peruvian Public Hospital.

Authors:  Marlon Yovera-Aldana; Sonia Pérez-Cavero; Isabel Pinedo-Torres; Carlos Zubiate-López
Journal:  Rev Diabet Stud       Date:  2022-03-09

6.  Predicting the risk of future diabetic foot ulcer occurrence: a prospective cohort study of patients with diabetes in Tanzania.

Authors:  Roozbeh Naemi; Nachiappan Chockalingam; Janet K Lutale; Zulfiqarali G Abbas
Journal:  BMJ Open Diabetes Res Care       Date:  2020-05

7.  Risk of diabetic foot ulcer and its associated factors among Bangladeshi subjects: a multicentric cross-sectional study.

Authors:  Palash Chandra Banik; Lingkan Barua; Mohammad Moniruzzaman; Rajib Mondal; Farhana Zaman; Liaquat Ali
Journal:  BMJ Open       Date:  2020-02-28       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.